EdgarLookup

Oncotelic Therapeutics, Inc. — POS AM Filings

10 POS AM filings on record

This page lists all POS AM filings submitted to the SEC by Oncotelic Therapeutics, Inc. (OTLC), sorted by most recent first. Each row links to the full filing on EdgarLookup. Oncotelic Therapeutics, Inc. has filed 10 POS AM documents with the SEC since 2004. To view all SEC filings by Oncotelic Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 25-NSE 3 4 4/A 424B2 424B3 424B4 424B5 424B7 425 5 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A DEFR14A EFFECT FWP NT 10-K NT 10-Q POS AM PRE 14A PRE 14C PRER14A PRER14C REGDEX RW S-1 S-1/A S-1MEF S-3 S-3/A S-4 S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A UPLOAD
Form Description Accession Number Filed Period
POS AM 0001641172-25-004872 Apr 15, 2025
POS AM 0001493152-24-015239 Apr 18, 2024
POS AM 0001493152-24-014484 Apr 12, 2024
POS AM 0001493152-23-013010 Apr 20, 2023
POS AM 0001493152-23-012414 Apr 17, 2023
POS AM 0001493152-22-011241 Apr 26, 2022
POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001193125-12-148094 Apr 3, 2012
POS AM POST EFFECTIVE AMENDMENT NO.3 TO FORM S-1 0000950123-11-053981 May 25, 2011
POS AM OXIGENE, INC. 0000950123-10-056041 Jun 4, 2010
POS AM OXIGENE, INC. 0000950123-09-035562 Aug 14, 2009